Department of Microbiology & Immunology, Institute of Biomedicine, the Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 7A, Goteborg, Sweden.
Vaccine. 2010 Mar 11;28(12):2363-6. doi: 10.1016/j.vaccine.2009.12.084. Epub 2010 Jan 9.
The workshop on vaccine adjuvants was held in July of 2009 at the European Commission in Brussels, with the goal of identifying key scientific priorities as they pertain to the development of effective vaccines against life-threatening diseases especially those associated with poverty, including HIV/AIDS, malaria and tuberculosis as well as neglected infectious diseases. On the basis of new advances in adjuvant research and related technology as well as potential challenges and roadblocks, six priorities were identified to accelerate development of improved or novel vaccine adjuvants for human use.
疫苗佐剂研讨会于 2009 年 7 月在布鲁塞尔的欧盟委员会举行，旨在确定与开发针对危及生命的疾病，特别是与贫困相关的疾病（包括艾滋病毒/艾滋病、疟疾和结核病以及被忽视的传染病）的有效疫苗有关的关键科学优先事项。基于佐剂研究和相关技术的新进展以及潜在的挑战和障碍，确定了六个优先事项，以加速开发用于人类的改良或新型疫苗佐剂。
